The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Insurers' Prior Authorization Pledge: One Year Later

Health insurers made a public promise to fix one of the most hated parts of American healthcare, and the early scorecard is mixed. In June 2025, payers pledged to simplify and reduce prior authorization requirements across plans covering 257 million Americans, a move first reported by The Wall Street Journal on June 20, 2025, according to Becker's Hospital Review.

The commitments include cutting the number of services that require sign-off, moving to standardized electronic submissions, honoring prior authorizations when patients switch plans, and speeding up decisions. Insurers have been vocal about their progress, pointing to fewer required approvals and new interoperable systems built on common data standards.

But Becker's reports that meaningful work remains. Full electronic standardization, faster turnaround times, and consistent execution across every plan are still in progress rather than complete. Prior authorization has long delayed care and burdened clinicians, so providers and patients will judge these pledges by results, not announcements. The next year will show whether the industry follows through.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.